Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject in Fatigue and Cerebral Dopamine Receptor Density
NCT03305705Phase 4Unknown
- Start
- Oct 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), fatigue. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)fatigue
Beyond the preview
Go deeper on NCT03305705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03305705.